These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034 [TBL] [Abstract][Full Text] [Related]
13. Evaluation and management of non-alcoholic steatohepatitis. Reid BM; Sanyal AJ Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1117-22. PubMed ID: 15489568 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between morphological diagnosis of NASH (non-alcoholic steatohepatitis) and liver function tests in a group of patients with morbid obesity]. Chavarría-Arciniega S; López-Alvarenga JC; Uribe-Uribe NO; Herrera-Hernández M; González-Barranco J Rev Invest Clin; 2005; 57(4):505-12. PubMed ID: 16315634 [TBL] [Abstract][Full Text] [Related]
18. Obesity-related non-alcoholic steatohepatitis and TGF-beta1 serum levels in relation to morbid obesity. Sepúlveda-Flores RN; Vera-Cabrera L; Flores-Gutiérrez JP; Maldonado-Garza H; Salinas-Garza R; Zorrilla-Blanco P; Bosques-Padilla FJ Ann Hepatol; 2002; 1(1):36-9. PubMed ID: 15114294 [TBL] [Abstract][Full Text] [Related]
19. Invasive and non-invasive investigations for non-alcoholic steatohepatitis (NASH): The other face of the coin of histology. Ahmed MH Med Hypotheses; 2006; 66(3):679-80. PubMed ID: 16289367 [No Abstract] [Full Text] [Related]